ASIS for GAMMAGARD in Primary Immunodeficiency

计划入组 60 人 · 首次发布于 2014 年 4 月 25 日

Minipooled-IVIG in Primary Immunodeficiency Disease

计划入组 15 人 · 首次发布于 2019 年 4 月 1 日

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

计划入组 50 人 · 首次发布于 2006 年 1 月 19 日

intravenous immunoglobulin (primary immunodeficiency disease)

Primary sclerosing cholangitis(Engitix )

primary immunization-booster TB vaccine

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

Southcoast Center For Primary & Specialty Care

United States

Kedrion Biopharma Secures FDA Approval for QIVIGY, First Proprietary IVIG Therapy for Primary Immunodeficiency

Subcutaneous Immunoglobulin 20% Effective for Primary Immunodeficiency

FDA Approves Takeda's GAMMAGARD LIQUID ERC, First Ready-to-Use Low IgA Immunoglobulin Therapy for Primary Immunodeficiency